-
Je něco špatně v tomto záznamu ?
The physiology of bilirubin: health and disease equilibrium
L. Vitek, TD. Hinds, DE. Stec, C. Tiribelli
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem, Research Support, N.I.H., Extramural
Grantová podpora
R01 DK121797
NIDDK NIH HHS - United States
P01 HL051971
NHLBI NIH HHS - United States
K01 HL125445
NHLBI NIH HHS - United States
P20 GM104357
NIGMS NIH HHS - United States
- MeSH
- bilirubin * metabolismus farmakologie MeSH
- hemoxygenasa-1 metabolismus MeSH
- kardiovaskulární nemoci * MeSH
- lidé MeSH
- reaktivní formy kyslíku metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Research Support, N.I.H., Extramural MeSH
Bilirubin has several physiological functions, both beneficial and harmful. In addition to reactive oxygen species-scavenging activities, bilirubin has potent immunosuppressive effects associated with long-term pathophysiological sequelae. It has been recently recognized as a hormone with endocrine actions and interconnected effects on various cellular signaling pathways. Current studies show that bilirubin also decreases adiposity and prevents metabolic and cardiovascular diseases. All in all, the physiological importance of bilirubin is only now coming to light, and strategies for increasing plasma bilirubin levels to combat chronic diseases are starting to be considered. This review discusses the beneficial effects of increasing plasma bilirubin, incorporates emerging areas of bilirubin biology, and provides key concepts to advance the field.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003643
- 003
- CZ-PrNML
- 005
- 20230425140756.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.molmed.2023.01.007 $2 doi
- 035 __
- $a (PubMed)36828710
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vitek, Libor $u Fourth Department of Internal Medicine and Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
- 245 14
- $a The physiology of bilirubin: health and disease equilibrium / $c L. Vitek, TD. Hinds, DE. Stec, C. Tiribelli
- 520 9_
- $a Bilirubin has several physiological functions, both beneficial and harmful. In addition to reactive oxygen species-scavenging activities, bilirubin has potent immunosuppressive effects associated with long-term pathophysiological sequelae. It has been recently recognized as a hormone with endocrine actions and interconnected effects on various cellular signaling pathways. Current studies show that bilirubin also decreases adiposity and prevents metabolic and cardiovascular diseases. All in all, the physiological importance of bilirubin is only now coming to light, and strategies for increasing plasma bilirubin levels to combat chronic diseases are starting to be considered. This review discusses the beneficial effects of increasing plasma bilirubin, incorporates emerging areas of bilirubin biology, and provides key concepts to advance the field.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a bilirubin $x metabolismus $x farmakologie $7 D001663
- 650 _2
- $a hemoxygenasa-1 $x metabolismus $7 D051547
- 650 12
- $a kardiovaskulární nemoci $7 D002318
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Hinds, Terry D $u Department of Pharmacology and Nutritional Sciences, Barnstable Brown Diabetes Center, Markey Cancer Center, University of Kentucky, Lexington, KY 40508, USA
- 700 1_
- $a Stec, David E $u Department of Physiology and Biophysics, Cardiorenal, and Metabolic Diseases Research Center, University of Mississippi Medical Center, Jackson, MS 39216, USA
- 700 1_
- $a Tiribelli, Claudio $u Fondazione Italiana Fegato-ONLUS, Trieste, Italy. Electronic address: ctliver@fegato.it
- 773 0_
- $w MED00006668 $t Trends in molecular medicine $x 1471-499X $g Roč. 29, č. 4 (2023), s. 315-328
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36828710 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140752 $b ABA008
- 999 __
- $a ok $b bmc $g 1924364 $s 1189852
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 29 $c 4 $d 315-328 $e 20230222 $i 1471-499X $m Trends in molecular medicine $n Trends Mol Med $x MED00006668
- GRA __
- $a R01 DK121797 $p NIDDK NIH HHS $2 United States
- GRA __
- $a P01 HL051971 $p NHLBI NIH HHS $2 United States
- GRA __
- $a K01 HL125445 $p NHLBI NIH HHS $2 United States
- GRA __
- $a P20 GM104357 $p NIGMS NIH HHS $2 United States
- LZP __
- $a Pubmed-20230418